{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:54:22Z","timestamp":1787946862353,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Northern Sydney Local Health Disctrict"},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40266-023-01011-x","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T06:03:06Z","timestamp":1679896986000},"page":"343-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TANGO: Development of Consumer Information Leaflets to Support TAperiNG of Opioids in Older Adults with Low Back Pain and Hip and Knee Osteoarthritis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6675-1689","authenticated-orcid":false,"given":"Alessandra C.","family":"Marcelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-0081","authenticated-orcid":false,"given":"Emma K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-752X","authenticated-orcid":false,"given":"David J.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-1501","authenticated-orcid":false,"given":"Sarah N.","family":"Hilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-9930","authenticated-orcid":false,"given":"Natali","family":"Jokanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0079-4862","authenticated-orcid":false,"given":"Ana Paula","family":"Carvalho-e-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-0683","authenticated-orcid":false,"given":"Manuela L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"issue":"5","key":"1011_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/joim.13026","volume":"287","author":"S Mathieson","year":"2020","unstructured":"Mathieson S, et al. What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies. J Intern Med. 2020;287(5):458\u201374.","journal-title":"J Intern Med"},{"issue":"6","key":"1011_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5694\/mja12.10168","volume":"196","author":"CM Harrison","year":"2012","unstructured":"Harrison CM, et al. Opioid prescribing in Australian general practice. Med J Aust. 2012;196(6):380\u20131.","journal-title":"Med J Aust"},{"issue":"8","key":"1011_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/pds.3776","volume":"24","author":"MR Larochelle","year":"2015","unstructured":"Larochelle MR, et al. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001\u20132010. Pharmacoepidemiol Drug Saf. 2015;24(8):885\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10137","key":"1011_CR4","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1016\/S0140-6736(18)30489-6","volume":"391","author":"NE Foster","year":"2018","unstructured":"Foster NE, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368\u201383.","journal-title":"Lancet"},{"issue":"5","key":"1011_CR5","doi-asserted-by":"publisher","first-page":"475.e1","DOI":"10.1016\/j.jpain.2017.12.001","volume":"19","author":"RZ Megale","year":"2018","unstructured":"Megale RZ, et al. Efficacy and safety of oral and transdermal opioid analgesics for musculoskeletal pain in older adults: a systematic review of randomized, placebo-controlled trials. J Pain. 2018;19(5):475.e1-475.e24.","journal-title":"J Pain"},{"issue":"3","key":"1011_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363\u201388.","journal-title":"Osteoarthritis Cartilage"},{"key":"1011_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/JPR.S168785","volume":"12","author":"R White","year":"2019","unstructured":"White R, et al. General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing. J Pain Res. 2019;12:467\u201375.","journal-title":"J Pain Res"},{"issue":"3","key":"1011_CR8","first-page":"27252","volume":"14","author":"A Baldini","year":"2012","unstructured":"Baldini A, Von Korff M, Lin EHB. A review of potential adverse effects of long-term opioid therapy: a practitioners guide. Prim Care Companion CNS Disord. 2012;14(3):27252.","journal-title":"Prim Care Companion CNS Disord."},{"key":"1011_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6380","volume":"350","author":"RA Deyo","year":"2015","unstructured":"Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350: g6380.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"1011_CR10","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.pain.2013.09.009","volume":"154","author":"MD Sullivan","year":"2013","unstructured":"Sullivan MD, Howe CQ. Opioid therapy for chronic pain in the United States: promises and perils. Pain. 2013;154(Suppl 1):S94-100.","journal-title":"Pain"},{"key":"1011_CR11","volume-title":"Opioid harm in Australia and comparisons between Australia and Canada","author":"Australian Institute of Health and Welfare","year":"2018","unstructured":"Australian Institute of Health and Welfare. Opioid harm in Australia and comparisons between Australia and Canada. Canberra: Australian Institute of Health and Welfare; 2018."},{"issue":"10","key":"1011_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","volume":"54","author":"CS Florence","year":"2016","unstructured":"Florence CS, et al. The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med Care. 2016;54(10):901\u20136.","journal-title":"Med Care"},{"issue":"3","key":"1011_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.joca.2017.11.001","volume":"26","author":"IN Ackerman","year":"2018","unstructured":"Ackerman IN, et al. Forecasting the future burden of opioids for osteoarthritis. Osteoarthr Cartil. 2018;26(3):350\u20135.","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"1011_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40266-022-00929-y","volume":"39","author":"R Virnes","year":"2022","unstructured":"Virnes R, et al. Opioids and falls risk in older adults: a narrative review. Drugs Aging. 2022;39(3):199\u2013207.","journal-title":"Drugs Aging"},{"issue":"2","key":"1011_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CIA.S1847","volume":"3","author":"DL Chau","year":"2008","unstructured":"Chau DL, et al. Opioids and elderly: use and side effects. Clin Interv Aging. 2008;3(2):273\u20138.","journal-title":"Clin Interv Aging"},{"issue":"5","key":"1011_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/pds.3934","volume":"25","author":"NA West","year":"2016","unstructured":"West NA, Dart RC. Prescription opioid exposures and adverse outcomes among older adults. Pharmacoepidemiol Drug Saf. 2016;25(5):539\u201344.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1011_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/bmjqs-2021-014186","volume":"31","author":"AJ Cross","year":"2022","unstructured":"Cross AJ, et al. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework. BMJ Qual Saf. 2022;31(5):387\u2013400.","journal-title":"BMJ Qual Saf"},{"key":"1011_CR18","doi-asserted-by":"crossref","unstructured":"Hamilton M, et al. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia. PAIN. 2022;163(4):e518\u2013e526.","DOI":"10.1097\/j.pain.0000000000002340"},{"issue":"10","key":"1011_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","volume":"30","author":"E Reeve","year":"2013","unstructured":"Reeve E, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793\u2013807.","journal-title":"Drugs Aging"},{"key":"1011_CR20","doi-asserted-by":"crossref","unstructured":"Niznik, J.D., Ferreri, S.P., Armistead, L.T. et al. Primary-Care Prescribers\u2019 Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults. Drugs Aging 39, 739\u2013748 (2022). https:\/\/doi.org\/10.1007\/s40266-022-00967-6","DOI":"10.1007\/s40266-022-00967-6"},{"issue":"649","key":"1011_CR21","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.3399\/bjgp16X685669","volume":"66","author":"E Reeve","year":"2016","unstructured":"Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552\u201360.","journal-title":"Br J Gen Pract"},{"issue":"7","key":"1011_CR22","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1093\/geronb\/gbx138","volume":"73","author":"K Weir","year":"2018","unstructured":"Weir K, et al. Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines. J Gerontol Ser B. 2018;73(7):e98\u2013107.","journal-title":"J Gerontol Ser B"},{"issue":"11","key":"1011_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/2042098618794165","volume":"9","author":"JP Turner","year":"2018","unstructured":"Turner JP, et al. Strategies to promote public engagement around deprescribing. Ther Adv Drug Saf. 2018;9(11):653\u201365.","journal-title":"Ther Adv Drug Saf."},{"issue":"6","key":"1011_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890\u20138.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1011_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2710.2005.00674.x","volume":"30","author":"WB Dollman","year":"2005","unstructured":"Dollman WB, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther. 2005;30(5):425\u201332.","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"1011_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/hex.12888","volume":"22","author":"T Greenhalgh","year":"2019","unstructured":"Greenhalgh T, et al. Frameworks for supporting patient and public involvement in research: Systematic review and co-design pilot. Health Expect. 2019;22(4):785.","journal-title":"Health Expect"},{"issue":"4","key":"1011_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1345\/aph.1L522","volume":"43","author":"DK Raynor","year":"2009","unstructured":"Raynor DK, Dickinson D. Key principles to guide development of consumer medicine information\u2014content analysis of information design texts. Ann Pharmacother. 2009;43(4):700\u20136.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1011_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1745-6215-14-80","volume":"14","author":"P Martin","year":"2013","unstructured":"Martin P, et al. An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial. Trials. 2013;14(1):80\u201380.","journal-title":"Trials"},{"issue":"12","key":"1011_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033303","volume":"9","author":"N Jokanovic","year":"2019","unstructured":"Jokanovic N, et al. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study. BMJ Open. 2019;9(12): e033303.","journal-title":"BMJ Open"},{"issue":"5","key":"1011_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11606-008-0520-5","volume":"23","author":"LD Chew","year":"2008","unstructured":"Chew LD, et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008;23(5):561\u20136.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"1011_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10447319509526110","volume":"7","author":"JR Lewis","year":"1995","unstructured":"Lewis JR. IBM computer usability satisfaction questionnaires: psychometric evaluation and instructions for use. Int J Hum-Comput Int. 1995;7(1):57\u201378.","journal-title":"Int J Hum-Comput Int."},{"key":"1011_CR32","unstructured":"Australian Commission on Safety Quality in Health Care. Health literacy: taking action to improve safety and quality. Australian Commission on Safety and Quality in Health Care; 2015."},{"issue":"3","key":"1011_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1037\/h0057532","volume":"32","author":"R Flesch","year":"1948","unstructured":"Flesch R. A new readability yardstick. J Appl Psychol. 1948;32(3):221.","journal-title":"J Appl Psychol"},{"key":"1011_CR34","doi-asserted-by":"crossref","unstructured":"Kincaid JP, et al. Derivation of new readability formulas (automated readability index, fog count and flesch reading ease formula) for navy enlisted personnel. Naval Technical Training Command, Millington TN Research Branch; 1975.","DOI":"10.21236\/ADA006655"},{"issue":"5","key":"1011_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.sapharm.2013.02.007","volume":"9","author":"DK Raynor","year":"2013","unstructured":"Raynor DK. User testing in developing patient medication information in Europe. Res Social Adm Pharm. 2013;9(5):640\u20135.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"1011_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40900-018-0100-8","volume":"4","author":"S Blackburn","year":"2018","unstructured":"Blackburn S, et al. The extent, quality and impact of patient and public involvement in primary care research: a mixed methods study. Res Involv Engagem. 2018;4(1):16\u201316.","journal-title":"Res Involv Engagem."},{"issue":"11","key":"1011_CR37","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1097\/j.pain.0000000000002270","volume":"162","author":"AV Langford","year":"2021","unstructured":"Langford AV, et al. \u201cThe lesser of two evils\u201d: a framework analysis of consumers\u2019 perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. Pain. 2021;162(11):2686\u201392.","journal-title":"Pain"},{"issue":"12","key":"1011_CR38","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1111\/bcp.13742","volume":"84","author":"CR Hansen","year":"2018","unstructured":"Hansen CR, et al. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. Br J Clin Pharmacol. 2018;84(12):2716\u201328.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1011_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jppr.1626","volume":"50","author":"E Reeve","year":"2020","unstructured":"Reeve E. Deprescribing tools: a review of the types of tools available to aid deprescribing in clincal practice. J Pharm Pract Res. 2020;50(1):98\u2013107.","journal-title":"J Pharm Pract Res"},{"key":"1011_CR40","volume-title":"Health literacy survey","author":"Australian Bureau of Statistics","year":"2018","unstructured":"Australian Bureau of Statistics. Health literacy survey. Canberra: Australian Bureau of Statistics; 2018."}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T07:53:05Z","timestamp":1681804385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01011-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"30 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. This study was funded by the North Sydney Local Health District Research Fund, NSW, Australia. DJH and MLF hold research fellowships from the National Health and Medical Research Council of Australia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Alessandra C. Marcelo, Emma K. Ho, Sarah N. Hilmer, Natali Jokanovic, Joanna Prior, Ana Paula Carvalho-e-Silva and Manuela L. Ferreira declare that they have no conflicts of interest in relation to this article. David J. Hunter provides consulting advice on scientific advisory boards for Pfizer, Lilly, TLCBio, Novartis, Tissuegene, and Biobone that has no relation to the submitted paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was approved by the Northern Sydney Local Health District Human Research Ethics Committee (Project Number: 2020\/570).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent regarding the participation and publication of de-identified data was obtained from all individual participants.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data generated and\/or analysed during the current study are included in this published article and its electronic supplementary information files.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study conception and design. Material preparation was performed by EH, NJ, MF, DH and SH. Data collection and analysis were performed by AM. The first draft of the manuscript was written by AM and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}